Biomarkers of septic shock to predict hospital mortality in major burns undergoing antimicrobial therapy during the systemic inflammatory response syndrome

Ítems similars

• Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers
  per: Sílvia Regina Cavani Jorge Santos, et al.
  Publicat: (2024)
• MONITORAMENTO SÉRICO DE PIPERACILINA-MEROPENEM POR LC-MS/MS PARA AVALIAÇÃO DA EFETIVIDADE DO REGIME DE DOSE EMPÍRICA E A ESTRATÉGIA DE INFUSÃO ESTENDIDA EM PACIENTES SÉPTICOS QUEIMADOS ATRAVÉS DA ABORDAGEM FARMACOCINÉTICA-FARMACODINÂMICA
  per: Paschoalina Romano, et al.
  Publicat: (2022)
• Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokineticpharmacodynamics approach based on serum levels to combat bacterial resistance
  per: Sílvia Regina Cavani Jorge Santos, et al.
  Publicat: (2023)
• Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies
  per: Sílvia Regina Cavani Jorge Santos, et al.
  Publicat: (2023)
• Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment
  per: David de Souza Gomez, et al.
  Publicat: (2014)